Abalos Therapeutics
GermanyEntry
2019
Hold
7yr
Status
Active
Who owns Abalos Therapeutics?
Abalos Therapeutics is currently owned by Gruenderfonds Ruhr through Gruenderfonds Ruhr I (2017 vintage), since 2019. Across its history, Abalos Therapeutics has been through 4 private equity ownership periods, detailed in the timeline below.
Hand-verified · updated 2026-07-03
Most recent investor
Gruenderfonds RuhrGruenderfonds Ruhr I · 2017 · VC
4 ownership periods · full history below
Key facts
HQGermany
SectorBiotech
StatusActive
Key takeaways
- ·Co-held by NRW.BANK, Boehringer Ingelheim Venture Fund, Gruenderfonds Ruhr and coparion since 2019.
- ·4 distinct PE sponsors across ownership cycles.
Ownership history
4 ownership periods · co-invest detected
Active
Co-invest · 4 holders · 2019 · present
NRW.BANKActive
2019 · present(7yr) · NRW.Venture · 2006 · VC
Gruenderfonds RuhrActive
2019 · present(7yr) · Gruenderfonds Ruhr I · 2017 · VC
coparionActive
2021 · present(5yr) · coparion · 2016 · VC
More from Gruenderfonds Ruhr I
Other portfolio companies in the same fund.
More PE-backed in Biotech
Comparable biotech deals from other GPs.
USTrack Abalos Therapeutics
Save this record to your watchlist and pick up your research where you left off. No spam.
Who could buy Abalos Therapeutics?
6 strategic and 114financial buyers match this company's sector and geography profile, ranked from verified European deal history.
Find likely buyersGet the full record on Abalos Therapeutics.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue